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Abstract
The assessment of left ventricular shape changes during cardiac revolution may be a new
step in clinical cardiology to ease early diagnosis and treatment. To quantify these changes,
only point registration was adopted and neither Generalized Procrustes Analysis nor Princi-
pal Component Analysis were applied as we did previously to study a group of healthy sub-
jects. Here, we extend to patients affected by hypertrophic cardiomyopathy the original
approach and preliminarily include genotype positive/phenotype negative individuals to ex-
plore the potential that incumbent pathology might also be detected. Using 3D Speckle
Tracking Echocardiography, we recorded left ventricular shape of 48 healthy subjects, 24
patients affected by hypertrophic cardiomyopathy and 3 genotype positive/phenotype nega-
tive individuals. We then applied Generalized Procrustes Analysis and Principal Compo-
nent Analysis and inter-individual differences were cleaned by Parallel Transport performed
on the tangent space, along the horizontal geodesic, between the per-subject consensuses
and the grand mean. Endocardial and epicardial layers were evaluated separately, different
from many ecocardiographic applications. Under a common Principal Component Analysis,
we then evaluated left ventricle morphological changes (at both layers) explained by first
Principal Component scores. Trajectories’ shape and orientation were investigated and
contrasted. Logistic regression and Receiver Operating Characteristic curves were used to
compare these morphometric indicators with traditional 3D Speckle Tracking Echocardiog-
raphy global parameters. Geometric morphometrics indicators performed better than 3D
Speckle Tracking Echocardiography global parameters in recognizing pathology both in
systole and diastole. Genotype positive/phenotype negative individuals clustered with
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patients affected by hypertrophic cardiomyopathy during diastole, suggesting that incum-
bent pathology may indeed be foreseen by these methods. Left ventricle deformation in pa-
tients affected by hypertrophic cardiomyopathy compared to healthy subjects may be
assessed by modern shape analysis better than by traditional 3D Speckle Tracking Echo-
cardiography global parameters. Hypertrophic cardiomyopathy pathophysiology was un-
veiled in a new manner whereby also diastolic phase abnormalities are evident which is
more difficult to investigate by traditional ecocardiographic techniques.
Introduction
Hypertrophic cardiomyopathy (HCM), due to its genetic aetiology with dominant autosomal
transmission and complete or incomplete penetrance, became a central subject in cardiology
although it presents a highly variable phenotypic, clinical and prognostic heterogeneity [1].
Around 65% of HCM patients have relatives with either genotype-positive/phenotype-positive
(g+p+) or genotype-positive/phenotype-negative (g+p-) status and more than 1400 mutations
carried by more than 13 genes were identified [2]. The two most common mutations include
myosine binding protein C3 (MYBPC3) and myosine heavy chain (MYH7) with an overall
70% prevalence whereas troponin T2 (TNNT2) mutations represent about 7% prevalence and
other mutations are quite rare [2,3].
Despite conserved ejection fraction (EF), systolic phase undergoes functional impairment in
HCM patients: magnetic resonance (RMN) and echocardiography are the most used diagnostic
tools and in particular speckle tracking echocardiography in either 2- or 3-dimensions
(2DSTE, 3DSTE) might be of great value [4]. Systolic dysfunction is evaluated by calculating
strains, twist and rotations whereas diastolic abnormalities are more difficult to be seen [5].
Longitudinal, radial and circumferential strains were attenuated and useful to index HCM pa-
tients as compared to healthy individuals [6,7]. On the other hand, it was shown that some ro-
tational parameters and trajectory attributes [5,8] are delayed during diastole in comparison to
healthy individuals, thus suggesting that also LV diastolic function is compromised in HCM
patients. Therefore, evaluating LV revolution during heart cycle might unveil new patterns in
HCM pathophysiology. More importantly, these investigations could be applied to g+p- indi-
viduals in order to assess if their “static” global shape or the shape of their LV morphological
trajectories are discriminant as compared to healthy individuals. Our approach allows answer-
ing important physiological questions: a) given the intimate relationship “form and function”,
which of these undergoes first the most serious modifications in affected individuals? b) which
of these is the most resistant to alterations caused by HCM? c) is epicardium or endocardium
in HCM patients the layer most setting apart from healthy individuals? d) is (and how much if
any) the natural epi-endocardial synchronism altered in HCM patients? e) is there any means
to assess quantitatively direct diastolic indicators in HCM? f) is there any means to index geno-
type from phenotype in HCM? Question e) and f) were faced recently using echocardiographic
studies. Ho et al [9] found some significant parameters in g+p- individuals using Doppler Tis-
sue Imaging thus suggesting that diastolic abnormalities are an early subclinical manifestation
of HCM, which precedes development of LV hypertrophy. More recently, Gruner et al [10]
used a variety of clinical and basic echocardiographic indicators to predict genotype in a wide
sample of subjects. Several authors provided a huge amount of studies (whose complete review
is not the scope of the present paper) illustrating functional LV impairments in HCM patients.
However, none of these used modern shape deformation analysis to evaluate LV shape changes
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in HCM and g+p- individuals via speckle tracking. This approach could help diagnosis and
prevention by looking for new preclinical indicators also during diastole.
Recently, Piras et al. [8] proposed a new method for the evaluation of LV motion using Pro-
crustes Motion Analysis and a modified Geometric Morphometrics toolkit in order to study
not only the shape of LV but also the shape, size and orientation of its trajectory in time. Their
approach used the concept of homologous times to identify comparable time frames at which
the LV shape is predicted for reconstructing its motion trajectory. A proper morphospace is
then built to correctly compare different trajectories by means of the “linear shift” strategy [8].
In the present investigation we aimed at comparing LV trajectories of HCM individuals to as-
sess the shape change pathophysiology underlying HCM as well as the attributes of its motion
trajectories when contrasted with healthy subjects. We evaluated the performance of both static
shape analyses and trajectory analysis by comparing them with classical global ecocardio-
graphic indicators. Moreover, we preliminary included 3 g+p- subjects as HCM family mem-
bers of patients included in our overall sample to explore the promise of the new approach
proposed here.
Methods
Subjects and Ethic statements
The study was conducted after the approval of the ‘‘Dipartimento di Scienze Cardiovascolari,
Respiratorie, Nefrologiche, Anestesiologiche e Geriatriche, Sapienza-Università di Roma” and
in accordance with the ethical guidelines of the Declaration of Helsinki. Written informed con-
sent was obtained from each subject. From April 2012 to April 2014, a total of 75 subjects were
studied. For 48 healthy subjects we assessed, based on an accurate cardiological visit, the ab-
sence of any type of known heart disease. There were 24 non-obstructive HCM patients.
Table 1 shows descriptive statistics of the sample under study. Moreover, there were 3 g+p- (1
with MYBPC3, 1 with MYH7 and 1 with TNNT2) family members of the HCM patients in-
cluded as a preliminary approach.
3D data acquisition
Our methods derive basically from Piras et al [8]. They introduced a new strategy for studying
motion applied to LV geometry moving in real time. Initially, the acquisition of LV geometry is
achieved by means of 3DSTE, a technique that became a gold standard in cardiological diagno-
sis as it allows the real time evaluation of LV motion and the measurements of several
Table 1. Descriptive statistics ± standard deviation for the populations under study.
Descriptive parameters Control = 48 HCM = 24
Age 39±8.64 47±12.39
Ejection Fraction 59.1±0.05 54.8±0.08
Inter-Ventricular Septum 8.48±1.41 18.16±3.84
Males/Females 32/16 14/10
Beat rate 77±13.16 75±13.00
Genetic Mutations for HCM
MYBPC3 - 7
MYH7 - 4
TNNT2 - 3
Mutation not known - 6
Not investigated - 4
doi:10.1371/journal.pone.0122376.t001
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diagnostic parameters such as twist, torsion, rotation among others. We collected LV shape
data by means of PST–25SX Artida device, Toshiba Medical Systems Corp., Tokyo, Japan. The
LV geometry is reconstructed starting from a set of 6 homologous landmarks, manually de-
tected by the operator for all subjects under study. The same operator (AE) was involved in LV
geometry reconstruction (Fig 1).
Fig 1. The Speckle Trackingmethodology. (A) Healthy control subject. (B) Individual affected by Hypertrophic Cardiomyopathy.
doi:10.1371/journal.pone.0122376.g001
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The manual detection for a set of landmarks is important as it allows recording the spatial
coordinates in comparable anatomical structures of different subjects following a homology
principle [11]. Fully automated approaches suffer from error of pattern identification depend-
ing on specific algorithms used for reconstruction [12–15]. The final dataset of any subject is a
time-sequence of shapes, each constituted by 1297 landmarks (assumed to be homologous) for
either the epicardial and endocardial surfaces, positioned along 36 horizontal circles, each com-
posed of 36 landmarks, plus the apex. It was possible to obtain the landmark cloud (upon
which the standard rotational, torsional and strain parameters are computed and outputted by
each Artida device) by an unlocked version of the software equipping our PST–25SX Artida de-
vice, thanks to a special opportunity provided in the context of an official research and devel-
opment agreement between the Dipartimento di Scienze Cardiovascolari, Respiratorie,
Nefrologiche Anestesiologiche e Geriatriche, ‘‘Sapienza”Università di Roma and Toshiba Med-
ical System Europe, Zoetermeer, The Netherland.
Procrustes Motion Analysis
The mean temporal resolution of our data is about 40 ms with a standard deviation of 6.19 ms.
It means that, on average, about 20 LV shapes changing in time are recorded within a single
beat. However, any subject is represented by a different number of LV shapes (min: 12; max:
33) captured within a single heart cycle depending on individual heart beat rate. In order to
properly define a set of motion trajectories constituted by the same number of shapes, we
therefore adopted the same strategy described in Piras et al. [8]. Our approach takes advantage
of the manual identification of time frames (expressed in ms) at which homologous electrome-
chanical events occur within any subject under study. This temporal homology is absolutely
critical as is anatomical homology in morphological studies [16]. In fact, comparing the attri-
butes of a set of trajectories (i.e. their shape, size and orientation) implies that the morphology
changing in time must be captured at physiologically homologous times. Heart revolution of-
fers the unique opportunity for recognizing events that are specifically homologous under elec-
trical and mechanical points of view. Apart end systolic volume and few others, there were no
previously constantly considered homologous electromechanical times in clinically oriented in-
vestigations before Piras et al. [8] whom used a complete set of homologous times in order to
study the shape of the morphological revolution itself. We then choose from visual inspection
of the electrocardiogram and echocardiographic videos associated to each 3DSTE registration,
3 electrical events (onset of R, end of T, and Q minimal waves) and 3 mechanical ones (end sys-
tolic volume, mitral-valve opening, end of rapid filling/beginning of diastasis) to obtain a se-
quence of electrophysiologically homologous times for each subject i: {t1, t2, t3, t4, t5, t6}
i, with t1 = R peak; t2 = end of T wave; t3 = end systolic volume; t4 = mitral-valve opening;
t5 = end of rapid filling/beginning of diastasis; t6 = Q min. We specify here that the end sys-
tolic volume time is assumed to be coincident (thus without error) with that provided by the
Artida device. Thus, LV shape at this time coincides with that estimated by the machine at that
time. Given a mean temporal resolution of 40 ms, it implies that the error is ±20 ms. This ap-
proximation is identically accepted by every experimental study published till now worldwide,
using a 3DSTE. Additionally, for a better interpolation of shapes over time, we added 3 median
points to the above-mentioned sequence: thk = median point between th and tk. Thus, the
final sequence of homologous times for subject ith comprises 9 times: hti = {t1, t1_2, t2, t3,
t4, t4_5, t5, t5_6, t6}. Fig 2 summarizes the interpolation procedure described above.
Once assessed the 9 time frames for any subject, we proceeded as follows to predict LV
shapes at these times for each individual. We denote here that all analyses described below
were performed on epicardial and endocardial shapes separately. This is crucial because
LV Trajectory in Hypertrophic Cardiomyopathy
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considering the two layers together fatally leads to a serious circular bias: the layers include the
myocardial thickness that is just the parameter upon which the HCM pathology is defined. An-
alyzing them separately eliminates this circularity and will lead to differential identification of
functional impairments affecting LV inner and outer strata. First, we performed separate Gen-
eralized Procrustes Analyses (GPA) for every subject in the dataset and a corresponding Princi-
pal Component Analysis (PCA). We carefully note that GPAs performed here or in the linear
shift (see below) are performed in both size and shape space [17], i.e. without scaling all subject
Fig 2. Interpolation of shape variables (here the sole PC1 is shown) at electrophysiological
homologous times. Note that homologous times are not equally spaced during cardiac revolution.
doi:10.1371/journal.pone.0122376.g002
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to the same size, and in the shape space thus removing size as commonly done in many Geo-
metric Morphometrics applications. The two approaches are compared and contrasted: the
first reason for this stems from the fact that contraction, thus reduction in size, represents an
important parameter of heart function. Size represents a genuine mechanical deformation even
when it does not affect shape. Moreover, in the case of data subjected to a linear shift (see
below), together with centering in shape, the size also is centered on the Grand Mean, thus
maintaining intra-individual size excursion but filtering out inter-individual size differences.
We then first perform separate (per-individual) GPAs+PCAs on the size and shape space (size
must be maintained at this stage: it can optionally be maintained or partialled out in the succes-
sive steps) and we predicted, for any subject separately, all PC scores explaining up to 100% of
total variance in correspondence of individual specific homologous time frames. We performed
this prediction by using a cubic spline interpolation (using spline() function in R package
‘‘stats”) on the relationships between time (in ms, as independent) and values of the PC scores
(as dependents). In some cases the homologous times are very close to the times at which the
machine acquires the data. Although the 3D frame rate has a lower resolution as compared to a
2D acquisition rate (~40 ms vs. ~20 ms, respectively), just by chance some of our homologous
times could coincide with the actual acquisition by the machine and those who may not be co-
incident might have a 20 ms maximum error, which in any case is a very tiny difference as
compared to the global systolic duration (~450 ms). As for the end systolic volume, we assume
(as stated before) that the machine acquisition represents the true value. Successively, using all
PC scores, we reconstructed the original LV shapes by using the subject specific eigenvalues
and eigenvectors computed during individual specific PCAs. At this stage we then have, for
any subject, a set of 9 epicardial and 9 endocardial shapes (each constituted by 1297 landmarks
in 3 dimensions) representing LV morphology captured at homologous electromechanical
events. We applied the new strategy of linear shift, described in Piras et al. [8] to these data.
The linear shift is essential in order to filter out initial inter-individual variability and leaving
just the motion path differences. The shifted data can be then subjected to a standard GPA
+PCA in the size and shape space or in the shape space. We used the values of the first 3 PC
scores coming from this last PCA as homologous landmarks representing 3-dimensional
shapes of LV trajectories. Then, these shapes are constituted by 9 landmarks in 3 dimensions
representing the LV trajectory in time. This step represents a second-order level of abstraction
as these shapes are no longer LV shapes but the shapes of LV trajectories themselves. We stress
here that trajectory attributes are not related to specific homologous times as they characterize
the entire LV revolution evaluated during the whole heart cycle. When testing orientation we
choose the angles between PC1-PC2 and PC1-PC3 using the PC scores of shapes predicted at
the first and fourth times that correspond to R-peak and end systolic volume, respectively.
Testing the shapes of the trajectories, we performed a GPA followed by a PCA in order to eval-
uate trajectories shape and size as done in Adams and Collyer [18], Collyer and Adams [19],
Collyer et al [20] and Piras et al. [8]. Median points cited above were excluded during Procrus-
tes Distance minimization process and were passively appended to transformations (transla-
tion, scaling and rotation) applied to PC values estimated at any t electromechanical
homologous time. This strategy allows to compare relatively complete shapes of trajectories
without adding noise due to non perfectly homologous physiologically-based event estimation.
For size of trajectories we computed the sum of phenotypic distances between any point inter-
polated for each trajectory.
LV Trajectory in Hypertrophic Cardiomyopathy
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Static shape analysis
For any homologous time we performed GPAs+PCAs in order to explore morphological differ-
ences between healthy subjects and HCM patients. We evaluated also, at any homologous
times, the shape differences for each individual from his proper shape at R peak, i.e. in teledias-
tole. These analyses were performed using respectively pure shapes in the size and shape space,
shapes transported in the size and shape space and shapes transported in the shape space. We
also performed corresponding UPGMA cluster analyses to explore the relationships between
healthy, HCM and g+p- individuals that evolve differently within the heart revolution.
UPGMAs were performed on euclidean distances among the 3 groups. Albeit these analyses
are properly static analyses of shape change, their meaning is profoundly dynamic, as they are
performed at electrophysiologically homologous times and, as a consequence, they should be
evaluated as whole time sequence.
Morphological integration
Endocardium and epicardium inevitably move together and they covary during cardiac revolu-
tion. However, this covariation could (or could not) undergo significant alteration when com-
paring healthy to pathological individuals. Moreover, as the landmarks of the speckle tracking
technology are virtually anchored to epicardial and endocardial tissues moving in time, they
can be used in order to assess which layer sets apart the most from healthy conditions during
LV cycle. A potentially important consequence of applying this interpretation could be that of
regionalization of myocardial disarray on one hand and that of the lever arm length (and cur-
vature) in the functional couple epicardium-endocardium [21,22] on the other. To test these
explicit hypotheses we use a conventional metrics used in Geometric Morphometrics: the RV
coefficient. RV coefficient is the multivariate version of the coefficient of correlation [23] and
varies from 0 to 1. As first, we assessed within any patient the RV coefficient between endocar-
dium and epicardium using the 9 epicardial and endocardial shapes at the corresponding ho-
mologous times. Then we used a permutated ANOVA to test for difference in RV between
healthy subjects and HCM patients. This was aimed at testing if epicardium and endocardium
are somewhat “desynchronized” in HCM patients. Another important inference was done by
comparing, separately, the epicardial and endocardial end systolic shapes of HCM patients ver-
sus healthy subjects. This was done on data transported (that we recall represent the deforma-
tion, not shapes per se) in the shape space thus filtering out size. This choice is justified upon
the following reasoning: in investigating the differential fate of epicardium and endocardium
during contraction and the consequences of HCM disease on their size and shape changes, it is
useful to know how much the global change is driven by homothetic contraction and how
much pertains to pure shape change. This is important because the muscular disarray in HCM
patients implies an inefficient contraction. This inefficiency could just decrease contraction (in
homothetic sense) or also entail a smaller change in terms of pure shape. As size is essential
during LV revolution, its removal is important for identifying where the effect of pathology
takes place, i.e on a reduced volumic contraction or also on pure shape.
Being shape multivariate, we build a 2 way permutated MANOVA design (employing the
first 10 PC scores values of data transported in the shape space at end systolic time) using con-
trol sample and HCM patients as primary factor and endocardium-epicardium as the second-
ary one. We then evaluated their interaction. In order to compare the design made on shape
variables with the behaviour of size, we performed the same analysis using the differences in
size from diastole and systole by means of an univariate 2 way ANOVA. We speculate that
knowing where interaction is significant could help in identifying (together with other
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observations) on which layer (epicardium or endocardium) and on which attributes (pure
shape or size) the anomalies due to HCM disarray operate.
Linear models
We used permutated MANOVA and ANOVA in order to test differences between the control
sample and HCM subjects for the various indicators we described above. Successively, we used
logistic regression, with pathological status coded as binary dependent, in order to evaluate the
performance of a different set of independent variables in discriminating healthy subjects from
HCM patients. Different models are then built depending on the different nature of predictors.
For any homologous time (t = 9) we evaluated separately all univariate descriptive parameters
outputted from 3DSTE (global strains, rotations and displacements) and the multiple set of
first 5 PC scores coming from static shape analyses. We chose only 3DSTE global parameters
because our morphometric analyses are performed on entire endocardial and epicardial shapes.
It is for further studies the subcomparison according to 16-segments ASE localization [24].
For static shape analyses (epicardium and endocardium), we evaluated the pure shapes in
the size and shape space, the shapes transported in the size and shape space, the shapes trans-
ported in the shapes space and, for any of these datasets, the shape differences at any homolo-
gous time from the shape at the R peak, i.e. in the same manner the 3DSTE parameters are
computed. Eventually, we also used the trajectory attributes: the multiple set of PC scores of
trajectory shape analysis and the univariate angles defined by PC1-PC2 and PC1-PC3 proper
of each subject-specific trajectory. We also used RV coefficient computed for any individual be-
tween epicardium and endocardium along the entire LV revolution. These last analyses cannot
be related to single homologous times as they come from the evaluation of trajectory attributes,
thus during the entire temporal LV revolution. As these models are not nested and can have
different number of predictors, the R-square cannot be considered as a metric for model per-
formance comparison. We choose, for critical evaluation of our logistic regression models, the
Akaike Information Criterion [25]. It represents the amount of information lost during model
construction and it accounts for the number of predictors. The smaller AIC indicates the pre-
ferred model. Using predicted values probabilities coming from the above mentioned logistic
regressions, we built a corresponding number of ROC curves and derived the “area under the
curve” (AUC). The AUC is often used as a measure of discrimination performance of different
indicators or treatments. We contrasted the best 3DSTE global indicators in systole and diasto-
le with our new morphometric indicators. Additionally, we contrasted AUCs of epicardium
and endocardium shapes transported in both size and shape space and shape space at 1th, 4th
and 7th homologous times thus covering the entire LV revolution. We used De Long et al. [26]
method in order to assess if 2 ROC curves are statistically different.
The relationship between Geometric Morphometrics indicators and
3DSTE parameters
In order to explore the meaning of the above mentioned indicators when compared to 3DSTE
parameters, we calculated the coefficient of correlation between 3DSTE global variables evalu-
ated at end systole with all morphometric indicators coming from the analyses described
above. As there is no specific time points whereby trajectory attributes are calculated, as previ-
ously stated, PC scores coming from static analysis, linear shifts and shape differences from the
R peak were instead correlated using PC values corresponding to end systolic time.
LV Trajectory in Hypertrophic Cardiomyopathy
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The preliminary inclusion of 3 g+p- individuals
The existence of g+p- individuals represents a challenge for HCM diagnosis and prevention.
The asymptomatic state of these subjects might force to genetic analysis solely on the basis of
HCM presence in their family history. By definition, their “phenotypic negativity” usually
makes classic echocardiography of scarce utility in their clinical identification. The logic behind
the inclusions of these 3 g+p- individuals rests on a preliminary assessment of the promise of
modern shape analyses we present here. In fact, coupling static shape analysis with the notion
of homologous times, will allow exploring their placement in ordination methods relatively to
healthy individuals and HCM patients in different phases of cardiac revolution, i.e. from systole
to diastole. An echocardiography-based method potentially able to predict the genotype state
in individuals “phenotipically negative” could be of high impact for their identification before
and independently from genetic analyses. Being the g+p- sample so small we just run an ex-
plorative cluster analysis without testing explicit hypotheses as done for HCM patients. These
analyses were done on pure epicardial and endocardial shapes in the size and shape space, on
shapes transported in the size and shape space and shapes transported in the shape space.
Results
Deformation analysis
Results of GPA+PCA performed on data shifted in the size and shape space are presented in
Fig 3 that shows both epicardial and endocardial trajectories.
We recall that these shape changes express solely the deformations not influenced from
shapes to which they apply. Animated version of these shape changes can be found in S1–S20
Figs. In this Supporting Information we also show the same results in the shape space thus not
considering size. We urge the reader to appreciate both the shape of the trajectories and the
shape changes explained by PCs illustrated in the above mentioned animations. As we per-
formed analyses of Fig 3 in the size and shape space, it is evident that the PC1 explains LV con-
traction while PC2 and PC3 are genuine shape changes not influenced by size. Individual
deformations along single PCs are useful in separating the contraction from pure shape
changes. Profound differences are visible passing from epicardium to endocardium. While
both PC1s illustrates a pure volume contraction, the other PCs tell us very different stories for
the two layers. For endocardium we see a shearing along PC2 and a bending-rotation along
PC3. Healthy and HCM individuals differ, as it can be seen on the 3D plot of epicardial trajec-
tory, mainly for the magnitude of their variations along PCs. On the opposite, for endocardi-
um, PC2 and PC3 point in opposite directions, passing from systole to diastole, in the 2
groups. Endocardial PC2 shows a shape lengthening that is inverted in HCM patients. The
same signal is evident along PC3 that explains a light basal expansion that tends to disappear
in systole. These dramatic differences between control and HCM individuals are also evident
in the trajectory 3D plot that clearly shows healthy and pathological trajectories that cross
each other.
Trajectory attributes analysis
Values of first 3 PC scores coming from the linear shift at any homologous times were treated
as homologous landmarks and subjected to GPA+PCA. Fig 4 and Fig 5 show results of these
analyses and the trajectories shapes explained by the first 3 PC scores of both size and shape
space and shape space.
For both the size and shape space and shape space, the PC1 represents the size of the trajec-
tories (correlation with trajectory size: R square = 0.99; p value = 0.001 for both epicardium
LV Trajectory in Hypertrophic Cardiomyopathy
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and endocardium) with the majority of the variance explained, while the other PCs are associ-
ated to pure shape deformations not related to size. Table 2 shows results relative to shape, size
and orientation of trajectories when analyzed under permutated ANOVA and MANOVA
models using control/HCM as factor.
All parameters resulted highly significant. The differences in multivariate shape of trajecto-
ries were significant even eliminating the PC1 that represents trajectory size. HCM patients are
shifted along PC1 toward values corresponding to smaller trajectories (Fig 4). However, among
the first 5 PC scores, looking at differences among single PCs, we found no significant differ-
ences among the PC2, while the PC3 shows significant differences between control and HCM
individuals. As it can be seen in Fig 5, the sides of PCs at which HCM individuals take place in
Fig 4 correspond to smaller and less rounded trajectories in comparison to shapes proper of
control sample positions. Fig 6 presents in box plots the distributions of univariate attributes of
morphological trajectories in the different groups for both size and shape space and
shape space.
For all these parameters, except for PC1-PC2 angle of epicardial trajectory, the comparison
between control and HCM individuals is statistically significant under permutated ANOVA.
An interesting result regards the size of endocardial trajectory shape that is significantly larger
than that of epicardium (p-value: 0.001). This holds also for data transported in the shape
space thus not considering size. It means that endocardium changes more than epicardium,
during its revolution, in terms of both size and pure shape.
Linear models
Results of logistic regressions (using control/HCM as a binary response), are shown in Table 3
and Table 4.
Fig 7 illustrates the course of AIC values at homologous times for static parameters and
trajectory attributes.
In particular, epicardial trajectory shape in the size and shape space and endocardial
PC1-PC3 angle in the shape space show very low AIC values. We contrasted the best 3DSTE
parameter in systole (Longitudinal displacement) and diastole (Regional global torsion) with
the endocardial shape transported in the size and shape space and epicardial shape transported
in the size and shape space respectively via ROC curves comparisons as shown in Fig 8.
Geometric Morphometrics parameters have always larger AUCs. De Long et al. [25] non
parametric approach suggests that for diastolic comparison the AUC difference is statistically
significant, while the systolic one is very close to significance. Fig 9 shows the comparison be-
tween endocardium and epicardium at relevant homologous times. From R peak to the end
systolic volume time, endocardium always predicts HCM better than epicardium, while in
meso-diastole their ROC curves are not significantly different.
Morphological Integration
As preliminary shown in Fig 6, RV coefficient between LV endocardium and epicardium dur-
ing heart revolution is smaller in HCM than in control sample. ANOVA shows this difference
as significant (p-value: 0.008). Results of the 2-way factorial design are shown in Fig 10.
Fig 3. The shape of trajectories and their morphological meaning in the size and shape space. (A) Epicardial trajectory. (B) Endocardial trajectory. (C)
Shape changes explained by the first three PC scores of epicardium. (D) Shape changes explained by the first three PC scores of endocardium. Animated
GIF of these figures are in the Supporting Information as well as the corresponding figures of data transported on the shape space.
doi:10.1371/journal.pone.0122376.g003
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Fig 4. PCA analyses performed on the shape of the trajectories themselves. PC1-PC2 and PC1-PC3
scatterplots are shown. (A) Size and shape space. (B) Shape space.
doi:10.1371/journal.pone.0122376.g004
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We show the course of the first single 4 PC scores and the combination of first 10 PC scores;
in this case, just for sake of visualization, the response variable in y-axis comes from a Canoni-
cal Correlation Analysis between first 10 PC scores of data shifted in the shape space corre-
sponding to end systolic volume homologous time and the numeric factor Control/HCM.
2-way permutated MANOVA was performed using the entire set of multivariate response.
Multivariate euclidean distances between the 2 categories (each with 2 levels) (Control/HCM/
Endocardium/Epicardium) can be found in Table 6.
Interaction was found only for the data shifted on the shape space, while for size we observe
parallel courses of Control/HCMEpicardium/endocardium. This result suggests that pure-
shape endocardial deformation in systole is larger than the epicardial one and that, passing
from healthy to HCM individuals, the majority of differences are found on the shape changes
of endocardium. Pure contraction of epicardium and endocardium, instead, scales equally in
Control and HCM individuals, being in HCM significantly smaller as repeatedly reported in
the Literature [4].
The relationship between Geometric Morphometrics indicators and
3DSTE parameters
Correlations between the various Geometric Morphometrics indicators described above and
original 3DSTE parameters are shown in S1 Table. Some indicators are correlated with classical
Fig 5. The shape of trajectories, constituted by the nine values of first three PC scores of LV shape interpolated at the nine homologous times,
explained by the first three PC scores of the LV trajectory shape analyses. (A) LV trajectories identified in the size and shape space. (B) LV trajectories
identified in shape space. We stress here that these PC scores are referred to the shape of the trajectories themselves not directly to the shape of LV.
doi:10.1371/journal.pone.0122376.g005
Table 2. Trajectories attributes ANOVA andMANOVA results for differences between the control sam-
ple and HCM individuals.
Epicardium size and shape space p-value
Size 0.001
Shape (first five PCs) 0.001
PC1-PC2 angle 0.015
PC1-PC3 angle 0.013
Endocardium size and shape space
Size 0.001
Shape (first five PCs) 0.001
PC1-PC2 angle 0.001
PC1-PC3 angle 0.001
Epicardium shape space p-value
Size 0.002
Shape (first five PCs) 0.006
PC1-PC2 angle 0.02
PC1-PC3 angle 0.01
Endocardium shape space
Size 0.07
Shape (first five PCs) 0.014
PC1-PC2 angle 0.001
PC1-PC3 angle 0.001
In bold significant results.
doi:10.1371/journal.pone.0122376.t002
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Fig 6. Box plots of the univariate attributes of trajectories. (A) Size and shape space. (B) Shape space.
doi:10.1371/journal.pone.0122376.g006
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3DSTE variables, while some trajectory attributes, such as angles, show significant correlations
with very few 3DSTE variables and with very weak correlation.
Static shape analysis at homologous time
Fig 11 shows the UPGMA analyses using the first 5 PCs for any static GPA+PCA (size and
shape space) performed at homologous times.
It is evident how in homologous times 3rd, 4th and 5th g+p- individuals clearly approach
HCM patients. Fig 12 and Fig 13 show the same analysis performed on data transported in the
Table 3. Logistic regression AIC and p-values for the 9 homologous times for 3DSTE parameters.
Toshiba Artida 3DSTE
parameters
R peak End of T
wave
Median End systolic
volume
Mitral
opening
Median Beginning of
diastasis
Median Q peak
Radial Strain_global 95.64 93.36 88.51 89.97 91.24 93.89 95.41 93.31 92.28
Circumferential Strain_global 95.65 94.83 80.1 78.43 83.76 91.42 94.84 95.24 95.59
Longitudinal Strain_global 95.22 86.47 65.05 65.58 76.98 93.42 95.41 95.66 95.6
Rotation_global 95.66 90.23 90.35 92.16 94.31 93.27 95.14 93.49 92.6
Twist_global 94.5 95.09 95.57 95.33 94.05 93.78 94.29 93.25 93.55
Torsion_Regional_global 95.43 94.78 92.59 93.06 95.55 94.4 92.62 90.39 91.36
Torsion_Basal_global 94.23 95.4 95.56 95.33 94.21 94.37 95.16 94.59 94.69
Strain_3D_global 95.61 88.64 82.1 84.45 85.73 89.64 95.39 95.43 94.42
Radial Displacement_global 94.11 95.24 89.34 89.59 92.4 94.11 95.51 95.65 95.65
Longitudinal Disp_global 90.85 64.77 60.27 64.61 74.22 94.01 95.44 93.67 94.26
X3DDisp_global 95.49 88.49 73.52 76.01 83.87 94.86 95.64 95.61 95.64
AreaTracking_global 95.57 92.36 74.71 72.84 80.72 91.78 95.45 95.48 95.66
Corresponding p-values
Radial Strain_global 8.86E-
01
1.44E-01 1.46E-
02
2.57E-02 4.60E-02 1.94E-
01
6.17E-01 1.33E-
01
7.48E-
02
Circumferential Strain_global 9.54E-
01
3.67E-01 1.50E-
03
1.34E-03 3.34E-03 5.18E-
02
3.67E-01 5.19E-
01
7.88E-
01
Longitudinal Strain_global 5.08E-
01
9.04E-03 6.45E-
05
6.25E-05 3.92E-04 1.47E-
01
6.22E-01 9.81E-
01
8.13E-
01
Rotation_global 9.58E-
01
2.60E-02 2.97E-
02
7.17E-02 2.52E-01 1.34E-
01
4.73E-01 1.50E-
01
9.51E-
02
Twist_global 3.08E-
01
4.58E-01 7.61E-
01
5.68E-01 2.12E-01 1.77E-
01
2.47E-01 1.33E-
01
1.68E-
01
Torsion_Regional_global 6.32E-
01
3.53E-01 9.32E-
02
1.20E-01 7.47E-01 2.72E-
01
9.13E-02 3.10E-
02
5.59E-
02
Torsion_Basal_global 2.52E-
01
6.11E-01 7.57E-
01
5.68E-01 2.36E-01 2.62E-
01
4.82E-01 3.05E-
01
3.33E-
01
Strain_3D_global 8.34E-
01
1.63E-02 1.83E-
03
3.38E-03 5.06E-03 2.34E-
02
6.05E-01 6.34E-
01
2.70E-
01
Radial Displacement_global 2.19E-
01
5.20E-01 2.00E-
02
2.35E-02 8.52E-02 2.25E-
01
6.98E-01 9.52E-
01
9.09E-
01
Longitudinal Disp_global 5.68E-
02
3.38E-05 2.22E-
05
2.75E-05 1.04E-04 2.08E-
01
6.38E-01 1.67E-
01
2.45E-
01
X3DDisp_global 6.78E-
01
1.30E-02 1.46E-
04
2.79E-04 2.16E-03 3.76E-
01
9.08E-01 8.35E-
01
8.97E-
01
AreaTracking_global 7.71E-
01
7.77E-02 4.93E-
04
4.55E-04 1.42E-03 5.98E-
02
6.47E-01 6.69E-
01
9.62E-
01
In bold significant results.
doi:10.1371/journal.pone.0122376.t003
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Table 4. Logistic regression AIC and p-values for the 9 homologous times for LV shape static parameters.
R peak End of T
wave
Median End systolic
volume
Mitral
opening
Median Beginning of
diastasis
Median Q peak
LV shapes in size and shape space
Epicardial shape 69.77 72.28 81.21 81.82 76.25 66.20 69.76 69.29 68.28
Endocardial shape 70.40 71.10 81.53 82.79 80.26 73.72 74.96 74.86 70.72
Epicardial shape differences from R peak 93.66 86.16 63.28 62.96 73.53 84.64 92.54 93.11 95.65
Endocardial shape differences from R
peak
93.66 91.60 74.18 75.10 81.10 88.08 95.01 94.97 95.58
Corresponding p-values
Epicardial shape 2.51E-
06
7.90E-06 4.30E-
04
5.61E-04 4.75E-05 4.86E-
07
2.49E-06 2.02E-
06
1.27E-
06
Endocardial shape 3.34E-
06
4.61E-06 4.95E-
04
8.57E-04 2.84E-04 1.52E-
05
2.66E-05 2.53E-
05
3.87E-
06
Epicardial shape differences from R peak NA 2.06E-03 1.27E-
08
1.08E-08 2.55E-06 9.05E-
04
7.75E-02 1.10E-
01
9.49E-
01
Endocardial shape differences from R
peak
NA 4.39E-02 3.59E-
06
5.79E-06 1.36E-04 5.92E-
03
4.21E-01 4.08E-
01
7.77E-
01
LV shape transported in the size and
shape space
Epicardial transported data 60.29 56.13 45.04 50.90 72.21 60.45 60.76 69.62 61.89
Endocardial transported data 34.17 73.35 41.16 44.90 42.99 81.51 72.12 70.66 56.93
Epicardial transported data differences
from R peak
93.66 83.88 57.61 57.57 66.67 75.69 88.00 89.38 95.56
Endocardial transported data differences
from R peak
93.66 90.29 71.07 72.08 78.21 84.92 94.77 94.85 95.60
Corresponding p-values
Epicardial transported data 3.11E-
08
4.44E-09 2.34E-
11
3.76E-10 7.64E-06 3.35E-
08
3.88E-08 2.34E-
06
6.57E-
08
Endocardial transported data 1.31E-
13
1.28E-05 3.69E-
12
2.20E-11 8.83E-12 4.91E-
04
7.34E-06 3.77E-
06
6.45E-
09
Epicardial transported data differences
from R peak
NA 6.00E-04 6.90E-
10
6.78E-10 7.28E-08 7.89E-
06
5.67E-03 1.22E-
02
7.50E-
01
Endocardial transported data differences
from R peak
NA 2.05E-02 7.10E-
07
1.20E-06 2.95E-05 1.05E-
03
3.45E-01 3.69E-
01
8.07E-
01
LV shape transported in the shape
space
Epicardial transported data 79.77 51.98 44.92 62.18 79.80 61.47 56.31 64.70 68.34
Endocardial transported data 43.58 74.89 45.44 44.72 41.95 83.15 75.46 72.67 61.34
Epicardial transported data differences
from R peak
93.66 95.00 87.49 86.50 86.87 85.86 90.43 92.00 95.38
Endocardial transported data differences
from R peak
93.66 94.70 91.34 90.80 89.28 88.19 93.26 93.26 95.61
Corresponding p-values
Epicardial transported data 2.29E-
04
6.28E-10 2.22E-
11
7.50E-08 2.31E-04 5.38E-
08
4.83E-09 2.42E-
07
1.30E-
06
Endocardial transported data 1.17E-
11
2.58E-05 2.84E-
11
2.01E-11 5.40E-12 1.00E-
03
3.33E-05 9.42E-
06
5.09E-
08
Epicardial transported data differences
from R peak
NA 4.16E-01 4.26E-
03
2.48E-03 3.02E-03 1.75E-
03
2.22E-02 5.58E-
02
6.01E-
01
Endocardial transported data differences
from R peak
NA 3.27E-01 3.77E-
02
2.76E-02 1.15E-02 6.27E-
03
1.21E-01 1.21E-
01
8.35E-
01
In bold significant results.
doi:10.1371/journal.pone.0122376.t004
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size and shape space and in the shape space. In this case g+p- approach HCM patients in the
endocardial deformation, in particular in meso-systole and meso-diastole.
Discussion
The results obtained in the present study insert in the broad range of investigations regarding
deformation in LV of HCM patients. We feel, however, that a new look to the traditional con-
cept of deformation, as applied in cardiovascular sciences, could help in identifying new poten-
tial indicators for diastolic dysfunction or for incumbent pathology. Geometric Morphometrics
represents an unexplored way to process echocardiographic data with the aim of unveiling LV
true shape deformation during cardiac morphological revolution. First, we stress that a defor-
mation should be always evaluated per se. Thus, the shape to which it applies should be
Fig 7. Results of logistic regressions using Control/HCM as a binary response and the entire bulk of morphological parameters used in this study.
The y-axis always represents the Akaike Information Criterion value for any analysis, while the x-axis represents the nine homologous times. Smaller AICs
indicate the best models. (A) STE global parameters; corresponding p-values can be found in Table 3. (B) Trajectory attributes in the size and shape space;
as these attributes are proper of the entire shape trajectory they are not referred to any particular homologous time; corresponding p-values can be found in
Table 5. (C) Trajectory attributes in the shape space: as these attributes are proper of the entire shape trajectory they are not referred to any particular
homologous time; corresponding p-values can be found in Table 5. (D) LV static shape analyses using pure shapes, shape transported in the size and shape
space and shapes transported in the shape space; corresponding p-values can be found in Table 4. (E) Shape differences from the R peak for the same
types of parameters in D; corresponding p-values can be found in Table 4. Among static parameters we found that global longitudinal displacement is the
best traditional descriptor at end systolic homologous time. Differences of pure epicardial shapes from R peak perform nearly in the same way. Static shapes
(pure shapes in size and shape space, shapes transported in the size and space and shapes transported in the shape space), instead, are performing also in
diastole. Endocardial shapes transported in both size and shape space and shape space show the lowest AICs. The courses of transported shapes and pure
shapes follow inverse patterns. All trajectory attributes returned significant logistic regressions (Table 5) except for endocardial trajectory size and RV
coefficient, both computed in the shape space.
doi:10.1371/journal.pone.0122376.g007
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disregarded if the goal is analyzing the intrinsic deformative process. To do that, the linear shift
is a suitable procedure for transporting a set of deformations toward a common shape. Trans-
porting separately endocardium and epicardium, leads to a finer appreciation of their differen-
tial fate during heart cycle. Some studies exist that analyzed the two layer separately [27–30].
These investigations highlight that epicardium and endocardium are better interpreted in
terms of deformation if evaluated independently. The same conclusion is supported here. Our
approach allows evaluating the shape of the trajectories themselves that are expression of func-
tion. Traditional 3DSTE indicators are usually computed as differences from the R peak. This
makes the study of diastolic dysfunction difficult as, approaching to the R peak, differences ap-
proach to 0 by definition. Moreover, these 3DSTE parameters do not discriminate between en-
docardium and epicardium behaviour. On the opposite, the use of Geometric Morphometrics
combined with the notion of homologous times, permits evaluating the diastolic phase in a
new manner because data are transported toward the Grand Mean that, in the context of LV
cycle, can be thought of as the mean shape between LV shapes at meso-systolic and meso-dia-
stolic phases. Transporting deformation, i.e. subtracting local means to any individual LV cycle
and adding the Grand Mean, means that even end diastolic phase is considered a true de-
formed state whereas usually, the sole end systolic time is interpreted in this way. All these
computations should be performed on endocardium and epicardium separately. In fact, their
trajectories are very different in both size and shape space and in the shape space. This can be
appreciated in Fig 3 and Fig 5 as well as upon the significant difference for trajectories attri-
butes existing between Control and HCM individuals (as shown in Table 2). In particular, the
endocardium shows very different PC1-PC3 angle that points in visibly opposite directions in
the 2 groups. This parameter is highly discriminating having an AIC much smaller of that of
Fig 8. ROC curves for the best STE descriptors and our best static morphometric descriptors in systole and diastole. (A) Endocardial shape
transported in the size and shape space vs. global longitudinal displacement. (B) Epicardial shape transported in the size and shape space vs. regional global
torsion. Shaded areas represent the 95% of confidence interval for ROC curves. The p-values refer to the Delong test for differences in ROC prediction.
doi:10.1371/journal.pone.0122376.g008
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Fig 9. ROC curves for epicardium and endocardium transported in the size and shape space and in the shape space in three meaningful
homologous times covering the entire cardiac revolution. (A-C) Size and shape space. (D-F) Shape space. Delong method was adopted to test
differences in ROC curve prediction.
doi:10.1371/journal.pone.0122376.g009
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traditional 3DSTE parameters associated to logistic regression (Fig 7). Besides orientation, the
shape of epicardial and endocardial trajectories are very different in both size and shape space
and shape space in Control and HCM individuals as depicted in Fig 5. HCM have much
smaller (PC1) and much less rounded (PC2 and PC3) trajectories in comparison to controls.
Fig 10. Two-way MANOVA (for shape) and ANOVA (for size) models. (A-D) Univariate interaction plots for the first 4 PCs of shape data transported in the
shape space; these plot are aimed at showing that single PCs behave in different manner thus making necessary the use of a the multivariate test. (E) Just
for sake of visualization we show the interaction plot where y-axis is represented by the Canonical Correlation scores coming from a multivariate model that
includes the first 10 PCs as a response and Control/HCM as binary predictor; multivariate euclidean distances between the 4 categories (Control/HCM/
Endocardium/Epicardium) can be found in Table 6. (F) Interaction plot for size.
doi:10.1371/journal.pone.0122376.g010
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The shape of epicardial trajectory in size and shape space possesses a very low AIC of logistic
regression. This is certainly due to the fact that the smaller contraction in HCM patients is de-
tected by the shape of epicardial trajectory in the size and shape space.
Separating epicardium and endocardium allows us appreciating their integration during LV
cycle: HCM patients show a significantly smaller morphological integration (relatively to Con-
trol) solely in the size and shape space. This means that their changes across the 9 homologous
times loose the normal covariation condition due to an abnormal contraction. In the shape
space this signal is not present. ROC curves clearly show that our morphometric indicators
perform better than traditional 3DSTE parameters (Fig 8). This is particularly true in diastole
because, as stated before, this phase is recognized by the linear shift procedure as a true de-
formed state. ROC curves of epicardium and endocardium show that endocardium predicts
pathology significantly better in systole in both size and shape space and shape space. This is
also evident by our 2-way MANOVA design performed on the shape space in systole: Control
and HCM individuals differ more for endocardium than for epicardium, while size scales
equally. This result could be used to speculate about the role of the muscular disarray affecting
HCM individuals: while the functional impairment of size equally affects epicardium and en-
docardium, the anomalies on pure shape are more evident in the endocardium. This means
that the endocardium, when passing from control to HCM conditions, shows a more severely
Table 5. Logistic regression AIC and p-values for trajectory attributes.
Size and shape space Shape space
Trajectory attributes AIC Trajectory attributes AIC
Epicardial trajectory shape 55.41 Epicardial trajectory shape 83.84
Epicardial PC1-PC3 angle 89.53 Epicardial PC1-PC3 angle 88.65
Epicardial trajectory size 61.26 Epicardial trajectory size 85.11
Endocardial trajectory shape 72.43 Endocardial trajectory shape 79.88
Endocardial PC1-PC3 angle 68.19 Endocardial PC1-PC3 angle 55.88
Endocardial trajectory size 74.019 Endocardial trajectory size 91.84
RV coefficient 87.91 RV coefficient 94.22
Corresponding p-values Corresponding p-values
Epicardial trajectory shape 0.0000 Epicardial trajectory shape 0.0013
Epicardial PC1-PC3 angle 0.0133 Epicardial PC1-PC3 angle 0.0080
Epicardial trajectory size 0.0000 Epicardial trajectory size 0.0010
Endocardial trajectory shape 0.0000 Endocardial trajectory shape 0.0002
Endocardial PC1-PC3 angle 0.0000 Endocardial PC1-PC3 angle 0.0000
Endocardial trajectory size 0.0000 Endocardial trajectory size 0.0500
RV coefficient 0.0054 RV coefficient 0.2300
In bold significant results.
doi:10.1371/journal.pone.0122376.t005
Table 6. Multivariate Euclidean distances between first 10 PC scores of data transported in the shape space for the 2 way MANOVA design.
Control Endocardium HCM Endocardium Control Epicardium HCM Epicardium
Control Endocardium 0.000 0.029 0.036 0.049
HCM Endocardium 0.029 0.000 0.033 0.041
Control Epicardium 0.036 0.033 0.000 0.020
HCM Epicardium 0.049 0.041 0.020 0.000
doi:10.1371/journal.pone.0122376.t006
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impaired systolic deformation in terms of pure shape in comparison to epicardium. Of course
this does not inform us about the location of muscular disarray: this information inevitably
should come from histo-pathological investigations [31]. However, the consequences of this
disarray could be evaluated upon the results we obtained here. Recently Martinez Lagazpi et al.
[32] investigated the role of vortex ring formation in LV filling for HCM pathology. They
found that in HCM patients the percentage of LV filling due to vortex formation is significantly
reduced in comparison to healthy subjects. They related this evidence with chamber sphericity.
This correlation between shape and vortex formation in diastole is highly suggestive here be-
cause pure shapes in size and shape space discriminate HCM better in diastole than in systole.
This could be interpreted as an evidence that systolic contraction “tries” to achieve a normal
shape due to the function that LV must fulfil irrespective of the pathological condition, while
in diastole the shape differences are more settling. When looking at transported data (in either
size and shape space or shape space) systole becomes more discriminating (Fig 7) because
these kinds of data represent a deformation not just a shape.
It is worth noting that our best trajectory indicator (i.e. PC1-PC3 angle for endocardial data
transported in the shape space), illustrated in Fig 7 and in S4 Fig, is significantly related only
with 3 out of 12 variables, having on top a weak correlation. This means that this parameter
represents something that is not captured by 3DSTE variables. The same holds true for other
indicators such as RV coefficient and PC1 of epicardial and endocardial shapes in the size and
Fig 11. UPGMA analyses performed at the nine homologous times on pure shapes. (A) Endocardial shapes. (B) Epicardial shapes. Circles represent
the analysis where g+p- individuals cluster together with HCM patients.
doi:10.1371/journal.pone.0122376.g011
LV Trajectory in Hypertrophic Cardiomyopathy
PLOS ONE | DOI:10.1371/journal.pone.0122376 April 13, 2015 24 / 33
Fig 12. UPGMA analyses performed at the nine homologous times on shapes transported on the size and shape space. (A) Epicardial shapes. (B)
Endocardial shapes. Circles represent the analysis where g+p- individuals cluster together with HCM patients.
doi:10.1371/journal.pone.0122376.g012
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Fig 13. UPGMA analyses performed at the nine homologous times on shapes transported on the shape space. (A) Epicardial shapes. (B)
Endocardial shapes. Circles represent the analysis where g+p- individuals cluster together with HCM patients.
doi:10.1371/journal.pone.0122376.g013
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shape space. On the other hand, other indicators correlate better with 3DSTE parameters and
this is expected in general terms since 3DSTE traditional parameters are calculated from the
same landmark clouds we used for our size and shape analyses. The fact that a trajectory attri-
bute correlates less may thus indicate that a genuine 4D approach could capture emergent
properties hardly derived from the calculation of any parameter evaluated at one single time
frame. Therefore, the information provided by the morphometric analyses might be considered
relatively independent from that given by 3DSTE traditional parameters and as such deserving
a special independent attention and study.
The preliminary inclusion of the 3 g+p- individuals deserves particular attention: using pure
shapes in the size and shape space they approach HCM in 5/9 homologous times for the epicar-
dial shape mainly in diastole (Fig 11). This is particularly important because diastolic dysfunc-
tion was hypothesized for g+p- individuals as evidence of incumbent pathology [33]. When the
deformation is investigated by using transported data, instead, the g+p- individuals cluster
with HCM patients (Fig 12 and Fig 13) for endocardial deformation in meso-systolic and
meso-diastolic phases. These evidences suggest that this type of investigation should be
Fig 14. Step by step flowchart of the entire procedure presented in the paper.
doi:10.1371/journal.pone.0122376.g014
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pursued using a larger sample of g+p- individuals because the possibility to predict genotype
from phenotype could help both prevention and treatment and could be far reaching.
It might be argued that a great deal of manual operations are needed to replicate our results
which is true at present since the software normally equipping Artida devices is not open
source being copyrighted by Toshiba. As a consequence the landmark cloud is not visible nor-
mally. On the other hand, it could be easy to implement that software by including the func-
tionalities illustrated in the conceptual flowchart depicted in Fig 14. It is foreseen that,
developing further the interest in morphometrics studies, the possible implementations looked
for above might soon become ready.
Supporting Information
S1 Fig. Trajectory PC1 PC2 PC3 of transported data of epicardium in the size and shape
space. Animated GIFs of trajectory shapes and morphologies associated to the first three PC
scores in both size and shape space and shape space. In green healthy subjects, in black HCM
individuals; numbers in the trajectories animations refer to the sequential 9 homologous times.
S1 Table reports orrelations between morphometric indicators described in the paper and tra-
ditional 3DSTE global parameters.
(GIF)
S2 Fig. Trajectory PC1 PC2 PC3 of transported data of epicardium in the shape space. Ani-
mated GIFs of trajectory shapes and morphologies associated to the first three PC scores in
both size and shape space and shape space. In green healthy subjects, in black HCM individu-
als; numbers in the trajectories animations refer to the sequential 9 homologous times. S1
Table reports orrelations between morphometric indicators described in the paper and tradi-
tional 3DSTE global parameters.
(GIF)
S3 Fig. Trajectory PC1 PC2 PC3 of transported data of endocardium in the size and shape
space. Animated GIFs of trajectory shapes and morphologies associated to the first three PC
scores in both size and shape space and shape space. In green healthy subjects, in black HCM
individuals; numbers in the trajectories animations refer to the sequential 9 homologous times.
S1 Table reports orrelations between morphometric indicators described in the paper and tra-
ditional 3DSTE global parameters.
(GIF)
S4 Fig. Trajectory PC1 PC2 PC3 of transported data of endocardium in the shape space.
Animated GIFs of trajectory shapes and morphologies associated to the first three PC scores in
both size and shape space and shape space. In green healthy subjects, in black HCM individu-
als; numbers in the trajectories animations refer to the sequential 9 homologous times. S1
Table reports orrelations between morphometric indicators described in the paper and tradi-
tional 3DSTE global parameters.
(GIF)
S5 Fig. PC1 Control and HCM transported data of endocardium in the size and shape
space. Animated GIFs of trajectory shapes and morphologies associated to the first three PC
scores in both size and shape space and shape space. In green healthy subjects, in black HCM
individuals; numbers in the trajectories animations refer to the sequential 9 homologous times.
S1 Table reports orrelations between morphometric indicators described in the paper and tra-
ditional 3DSTE global parameters.
(GIF)
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S6 Fig. PC1 Control and HCM transported data of endocardium in the shape space. Ani-
mated GIFs of trajectory shapes and morphologies associated to the first three PC scores in
both size and shape space and shape space. In green healthy subjects, in black HCM individu-
als; numbers in the trajectories animations refer to the sequential 9 homologous times. S1
Table reports orrelations between morphometric indicators described in the paper and tradi-
tional 3DSTE global parameters.
(GIF)
S7 Fig. PC1 Control and HCM transported data of epicardium in the size and shape space.
Animated GIFs of trajectory shapes and morphologies associated to the first three PC scores in
both size and shape space and shape space. In green healthy subjects, in black HCM individu-
als; numbers in the trajectories animations refer to the sequential 9 homologous times. S1
Table reports orrelations between morphometric indicators described in the paper and tradi-
tional 3DSTE global parameters.
(GIF)
S8 Fig. PC1 Control and HCM transported data of epicardium in the shape space. Animat-
ed GIFs of trajectory shapes and morphologies associated to the first three PC scores in both
size and shape space and shape space. In green healthy subjects, in black HCM individuals;
numbers in the trajectories animations refer to the sequential 9 homologous times. S1 Table re-
ports orrelations between morphometric indicators described in the paper and traditional
3DSTE global parameters.
(GIF)
S9 Fig. PC2 Control and HCM transported data of endocardium in the size and shape
space. Animated GIFs of trajectory shapes and morphologies associated to the first three PC
scores in both size and shape space and shape space. In green healthy subjects, in black HCM
individuals; numbers in the trajectories animations refer to the sequential 9 homologous times.
S1 Table reports orrelations between morphometric indicators described in the paper and tra-
ditional 3DSTE global parameters.
(GIF)
S10 Fig. PC2 Control and HCM transported data of endocardium in the shape space. Ani-
mated GIFs of trajectory shapes and morphologies associated to the first three PC scores in
both size and shape space and shape space. In green healthy subjects, in black HCM individu-
als; numbers in the trajectories animations refer to the sequential 9 homologous times. S1
Table reports orrelations between morphometric indicators described in the paper and tradi-
tional 3DSTE global parameters.
(GIF)
S11 Fig. PC2 Control and HCM transported data of epicardium in the size and shape
space. Animated GIFs of trajectory shapes and morphologies associated to the first three PC
scores in both size and shape space and shape space. In green healthy subjects, in black HCM
individuals; numbers in the trajectories animations refer to the sequential 9 homologous times.
S1 Table reports orrelations between morphometric indicators described in the paper and tra-
ditional 3DSTE global parameters.
(GIF)
S12 Fig. PC2 Control and HCM transported data of epicardium in the shape space. Ani-
mated GIFs of trajectory shapes and morphologies associated to the first three PC scores in
both size and shape space and shape space. In green healthy subjects, in black HCM individu-
als; numbers in the trajectories animations refer to the sequential 9 homologous times. S1
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Table reports orrelations between morphometric indicators described in the paper and tradi-
tional 3DSTE global parameters.
(GIF)
S13 Fig. PC3 Control and HCM transported data of endocardium in the size shape space.
Animated GIFs of trajectory shapes and morphologies associated to the first three PC scores in
both size and shape space and shape space. In green healthy subjects, in black HCM individu-
als; numbers in the trajectories animations refer to the sequential 9 homologous times. S1
Table reports orrelations between morphometric indicators described in the paper and tradi-
tional 3DSTE global parameters.
(GIF)
S14 Fig. PC3 Control and HCM transported data of endocardium in the shape space. Ani-
mated GIFs of trajectory shapes and morphologies associated to the first three PC scores in
both size and shape space and shape space. In green healthy subjects, in black HCM individu-
als; numbers in the trajectories animations refer to the sequential 9 homologous times. S1
Table reports orrelations between morphometric indicators described in the paper and tradi-
tional 3DSTE global parameters.
(GIF)
S15 Fig. PC3 Control and HCM transported data of epicardium in the size and shape
space. Animated GIFs of trajectory shapes and morphologies associated to the first three PC
scores in both size and shape space and shape space. In green healthy subjects, in black HCM
individuals; numbers in the trajectories animations refer to the sequential 9 homologous times.
S1 Table reports orrelations between morphometric indicators described in the paper and tra-
ditional 3DSTE global parameters.
(GIF)
S16 Fig. PC3 Control and HCM transported data of epicardium in the shape space. Ani-
mated GIFs of trajectory shapes and morphologies associated to the first three PC scores in
both size and shape space and shape space. In green healthy subjects, in black HCM individu-
als; numbers in the trajectories animations refer to the sequential 9 homologous times. S1
Table reports orrelations between morphometric indicators described in the paper and tradi-
tional 3DSTE global parameters.
(GIF)
S17 Fig. PC1 PC2 PC3 Control and HCM transported data of endocardium in the size and
shape space. Animated GIFs of trajectory shapes and morphologies associated to the first three
PC scores in both size and shape space and shape space. In green healthy subjects, in black
HCM individuals; numbers in the trajectories animations refer to the sequential 9 homologous
times. S1 Table reports orrelations between morphometric indicators described in the paper
and traditional 3DSTE global parameters.
(GIF)
S18 Fig. PC1 PC2 PC3 Control and HCM transported data of endocardium in the shape
space. Animated GIFs of trajectory shapes and morphologies associated to the first three PC
scores in both size and shape space and shape space. In green healthy subjects, in black HCM
individuals; numbers in the trajectories animations refer to the sequential 9 homologous times.
S1 Table reports orrelations between morphometric indicators described in the paper and tra-
ditional 3DSTE global parameters.
(GIF)
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S19 Fig. PC1 PC2 PC3 Control and HCM transported data epicardium in the size and
shape space. Animated GIFs of trajectory shapes and morphologies associated to the first three
PC scores in both size and shape space and shape space. In green healthy subjects, in black
HCM individuals; numbers in the trajectories animations refer to the sequential 9 homologous
times. S1 Table reports orrelations between morphometric indicators described in the paper
and traditional 3DSTE global parameters.
(GIF)
S20 Fig. PC1 PC2 PC3 Control and HCM transported data of epicardium in the shape
space. Animated GIFs of trajectory shapes and morphologies associated to the first three PC
scores in both size and shape space and shape space. In green healthy subjects, in black HCM
individuals; numbers in the trajectories animations refer to the sequential 9 homologous times.
S1 Table reports orrelations between morphometric indicators described in the paper and tra-
ditional 3DSTE global parameters.
(GIF)
S1 Table. Correlations between morphometric indicators described in the paper and tradi-
tional 3DSTE global parameters. In bold significant results.
(DOC)
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